Additional TrkA-fused oncogenes have since been identified, with low frequencies in many common adult cancers and with higher frequencies in some rare tumor types, including secretory breast carcinoma, mammary analogue secretory carcinoma, and congenital infantile fibrosarcoma [8,9]. This evidence concerns the gene NTRK1 and neoplasm.